Tech Company Financing Transactions
Guardant Health Funding Round
Guardant Health closed a $30 million Series B funding round on 4/22/2014. Investors included Khosla Ventures, Pear VC and Sequoia Capital.
Transaction Overview
Company Name
Announced On
4/22/2014
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series B
Investors
Proceeds Purpose
The additional financing will allow Guardant Health to accelerate the expansion of its commercial operations to support growing demand and ensure a distinctively high level of service for our physicians and patients.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
505 Penobscot Dr.
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Website
Email Address
Overview
Guardant360 is the only biopsy-free tumor sequencing test that tracks tumor genomics in real-time.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Helmy Eltoukhy
Chief Financial Officer
Derek Bertocci
President
AmirAli Talasaz
Vice President
Darya Chudova
VP - Bus. Development
Daniel Simon
VP - General Counsel
Michael Wiley
VP - Operations
Andrew Ament
VP - Regulatory Affairs
Morteza Minaee
Browse more venture capital transactions:
Prev: 4/22/2014: Orthopaedic Synergy venture capital transaction
Next: 4/23/2014: Yerdle venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs